New Approvals

This category is used for all new drugs that is recently approved by United States Food And Drugs Administration (FDA).

Dovato: Uses, Side Effects, Precautions, Dosage & FAQs

Dovato is a recently approved HIV/AIDS medicine. It is the brand name for the two antiretroviral medications (Dolutegravir and Lamivudine) to treat Human Immunodeficiency Virus-1 (HIV-1)/AIDs in adults and in children aged above 12 years.  Dovato is the first once-daily, two-drugs, single tablet, and complete regime approved by the US Food and Drugs Administration (FDA) […]

Dovato: Uses, Side Effects, Precautions, Dosage & FAQs Read More »

FDA Approves (Opdivo and Yervoy) for Treating Mesothelioma

The US food and drug administration has recently approved a combination therapy (Opdivo and Yervoy) to treat adults with unresectable malignant pleural mesothelioma. This is the first combo drug approval for mesothelioma in 16 years. Mesothelioma is a rare and aggressive type of cancer that is caused by inhaling asbestos. Opdivo and Yervoy Opdivo (nivolumab)

FDA Approves (Opdivo and Yervoy) for Treating Mesothelioma Read More »

New Oral Capsule can deliver insulin through microneedles in the stomach

Researchers at the Koch Institute have created a blueberry-sized capsule that can be used to administer oral insulin doses. It can replace the injections that people with type 2 diabetes should give up every day. Insulin is a peptide hormone produced by the β-cells of the pancreas. This enables the body to regulate the amount of

New Oral Capsule can deliver insulin through microneedles in the stomach Read More »

FDA Clears New Antibiotic Arikayce for Lung Disease

The FDA announced it has given Insmed, Inc. approval for Arikayce, a brand new drug developed for the treatment of lung disorder brought on by Mycobacterium avium complicated. “As bacteria continue to develop to currently available antibiotics, we must promote the development of drugs which may treat resistant infections,” FDA Commissioner Scott Gottlieb, MD, stated

FDA Clears New Antibiotic Arikayce for Lung Disease Read More »

FDA Approves A New Drug (Galcanezumab) For Migraine Treatment

The new medication is named Emgality (Galcanezumab) and can be used particularly to stop migraines,and it is manufactured by drug giant Eli Lilly. The medication has a record price of $575 per month, approximately $6,900 annually. Until May, there were not any drugs available now which were initially approved for relieving migraines, even however other

FDA Approves A New Drug (Galcanezumab) For Migraine Treatment Read More »